Home > Education Hub > We Announce our Role as Strategic Advisor to Benvic in the Acquisition of Luc & Bel

We Announce our Role as Strategic Advisor to Benvic in the Acquisition of Luc & Bel

Drawing on CDMO and biomedical expertise, Alira Health helped AGC Biologics become one of the few companies offering both plasmid production and cell and gene therapy services.

News

Category:

M&A

Published on:

November 29, 2020

We are proud to announce our role as strategic advisor to Benvic in the acquisition of Luc & Bel.

Benvic is a French group leader in the production of highly innovative PVC-based thermoplastic solutions and ecological biopolymers.

For more information, please contact Gabriele Brambilla.

To read the full press release

Click here

Related news

Publications February 24, 2021

What You Should Know Before Choosing a Healthcare Transaction Advisory Firm

What’s most important when selecting a firm for your next transaction? Global experience, staff profiles, technical expertise? To learn more download our latest TAD Infographic.

News December 20, 2020

We Announce our role as Strategic Advisor to Mérieux Equity Partners and Mérieux Participations 3 for Entering the Capital of CTRS

We are pleased to announce our role as strategic advisor to Mérieux Equity Partners as they join the Series A financing round of Cell-Easy, through Mérieux’s newly established venture fund, OMX.

Publications November 1, 2020

Five Key Success Factors for Managing Transactions in Full Virtual Mode

It is no secret that the COVID-19 pandemic has presented new challenges for businesses, and virtual has become the ‘new normal’, including for transactions.

Publications October 10, 2020

Q3 2020 Medical Device Contract Development and Manufacturing M&A Report

Despite the COVID-19 pandemic, M&A activity in the global CDMO industry has been exceptionally strong in 2020 with a record number of transactions completed during the third quarter alone.

News September 11, 2020

We Announce our Role as Advisor to Sagard NewGen

We are pleased to announce our role as Advisor to Sagard NewGen for the equity investment in Laboratoires Delbert. This recent capital raise of €40m supports the company’s growth(...)

News August 20, 2020

We Announce our Role as Exclusive Strategic Advisor to AGC Biologics in its Acquisition of MolMed SpA

We are proud to announce our role as strategic advisor to AGC Biologics, a leading global biopharmaceutical contract development, and manufacturing organization, in their acquisition(...)

News July 30, 2020

We Announce our Role as a Transaction Advisor to Daiichi Sankyo on the Sale of LOPRESSOR®, ICAZ®, and MIOREL® to SIT Laboratorio Farmaceutico (DESMA HC Group)

Daiichi Sankyo France /(hereafter, Daiichi Sankyo) and SIT Laboratorio Farmaceutico (DESMA HC Group) are pleased to announce the acquisition of LOPRESSOR®, ICAZ® and MIOREL® by SIT(...)

Our locations around the globe

USA, Boston

1 Grant Street, Suite 400, Framingham, Boston,
MA 01702, USA
+1 (774) 777 5255

USA, San Francisco

San Francisco, CA 94108, USA
+1 (774) 777 5255

France

12 Rue Charlot
75003 Paris, France
+33 (0)9 72 16 55 57

Germany

Kurfürstenstraße 22
80801 Munich, Germany
+49 (89) 416 14 22-0

Italy

Via Carlo Ottavio
Cornaggia 10, 20123 Milan, Italy
+39 (02) 36680198

Spain

Carrer de Balmes, 206 – Ático 2 08006 Barcelona, Spain
+34 (0)93 737 65 70

Switzerland, Geneva

Campus Biotech Innovation Park
Avenue de Sécheron 15
1202 Geneva, Switzerland
+33 (7) 69677361
+41 (79) 5937886

Switzerland, Basel

Badenstrasse 3
4056 Basel, Switzerland
+41 (0)61 205 9669

Contact us